Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage

Archives of Ophthalmology
R N JohnsonE Hernandez

Abstract

Intraocular recombinant DNA human tissue-type plasminogen activator (tPA) can promote rapid resolution of intracular fibrin clots and hyphema. The efficacy of intravitreal tPA in promoting the short-term clearance of vitreous hemorrhage was investigated. Five treatment groups with experimentally induced vitreous hemorrhage were studied. The extent of the vitreous hemorrhage was graded based on the visibility of retinal details in each quadrant. Two weeks following intravitreal tPA injection (50,000 IU), the nonvitrectomized group and gas vitrectomy groups, each of which received a single tPA injection, showed a statistically significant reduction of the vitreous hemorrhage, although this was thought to represent only a modest clinical effect. Tractional retinal detachments were noted to develop more frequently in tPA-treated eyes as compared with controls.

Citations

Feb 15, 1991·American Journal of Ophthalmology·H LewisB R Straatsma
Jul 1, 1997·The British Journal of Ophthalmology·P EsserM Weller
Jul 1, 1997·Survey of Ophthalmology·C W Spraul, H E Grossniklaus
Feb 1, 1994·Australian and New Zealand Journal of Ophthalmology·L M Manning, D K Conrad
Apr 1, 1993·International Ophthalmology·C KoutsandreaP Theodossiadis
May 8, 2009·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Wen-Chuan WuYo-Chen Chang
Mar 1, 1993·Journal of Cataract and Refractive Surgery·G R LesserR J Cionni
Jan 30, 2013·Australian Veterinary Journal·D I Rendle, K J Hughes
Sep 27, 2001·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·W C WuC W Chang
Jul 2, 2003·Drugs & Aging·Kaykhosrov Manuchehri, Graham Kirkby
Apr 5, 2000·Seminars in Ophthalmology·M KameiH Lewis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.